Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: London Closes Mixed As Oil Prices Resume Fall

Mon, 12th Jan 2015 17:11

LONDON (Alliance News) - UK shares gave up their earlier gains Monday as oil prices resumed their slide, while European stocks were boosted by a report setting out the mechanics of a widely anticipated quantitative easing programme by the European Central Bank.

In a day with little fresh economic data, London shares opened higher and maintained their gains for most of the trading session. However, the FTSE 100 and FTSE 250 indices incurred sharp losses after US indices quickly overturned a higher open, though the FTSE 100 managed to recover somewhat in late trade.

The FTSE 100 closed flat at 6,501.42, while the FTSE 250 closed down 0.4% at 15,943.69. The small-cap AIM All-Share managed a gain, however, closing 0.1% higher at 703.92.

Stocks in mainland Europe outperformed London, as talk of ECB quantitative easing drove equities. CNBC reported Monday that the ECB could be set to reveal a program of quantitative easing whereby the amount of sovereign debt to be purchased by the ECB would be determined by the level of contributions made by each national central bank within the eurozone.

The next ECB monetary policy decision announcement and press conference by President Mario Draghi is set for January 22.

The CAC 40 in Paris ended up 1.2%, and the DAX 30 in Frankfurt closed up 1.4%.

At the London close, Wall Street was trading broadly lower. The DJIA was down 0.4%, the S&P 500 and Nasdaq Composite were both down 0.6%. The fourth-quarter reporting season in the US will get underway Monday with the release of aluminium producer Alcoa's fourth-quarter earnings report after the close of US trading.

Oil prices continued their downward path, with Brent falling below USD48 a barrel for the first time since the end of March 2009. At its lowest level of the day, Brent touched USD47.16 a barrel. The US benchmark West Texas Intermediate dropped to its lowest level since late April 2009. WTI hit a low of USD45.88 a barrel.

Oil-related stocks were amongst the biggest fallers in the FTSE 100 and FTSE 250. BG Group, down 3.6%, and Royal Dutch Shell 'B', down 1.6%, were amongst the biggest blue-chip losers. Hunting, down 8.1%, Premier Oil, down 6.7%, John Wood Group and SOCO International, both down 4.9%, Ophir Energy, down 4.8%, and Petrofac and Cairn Energy, both down 4.3%, were amongst the worst mid-cap performers.

Gold miners Fresnillo, up 1.1%, and Randgold Resources, up 1.0%, benefited as gold prices rose towards the end of trade. Gold rose to a high of USD1,231.23 an ounce, the yellow metal's highest level since December 11.

Afren, down 22%, was by far the biggest faller in the FTSE 250, hitting its lowest level since the end of March 2009. The oil and gas explorer said it is considering its options for the Barda Rash field in the Kurdistan region of Iraq after the reserve estimate for the prospect was revised down substantially.

Afren said an updated competent person's report on the Barda Rash field is expected to show a material reduction to its previously-published estimates on reserves and resources. The explorer said it expects the total reserve estimate for the field to be revised down to 250 million barrels of oil from 1.24 billion barrels previously.

AO World, up 6.6%, closed as the best mid-cap performer. The online domestic appliances retailer said website revenue rose 38% in its fiscal third quarter which includes the key Christmas trading period, with sales spiking around Black Friday but remaining strong in the run-in to the festive season. It added that it remains confident that it will meet full-year expectations.

Hikma Pharmaceuticals, up 4.3%, was another big riser in the FTSE 250. The company said it will now prepare to launch its colchicine 0.6 milligram capsules, after Takeda Pharmaceuticals USA Inc failed in its bid to block the distribution of the capsules. The US District Court for Delaware had denied Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine capsules, and Himka said Monday that Takeda was unsuccessful in appealing this decision.

In the economic calendar Tuesday, Chinese new loans and trade balances data for December will be issued at 0200 GMT. UK consumer and producer price readings for December will be at 0930 GMT. The Kantar Worldpanel will release its latest UK grocery market-share figures for the 12 weeks ending January 4 at 0930 GMT.

In the corporate calendar, supermarket Wm Morrisons Supermarkets will be issuing a trading statement, as will bakery chain Greggs and fund manager Rathbone Brothers. Department store Debenhams, pub owner Spirit Pub Co and self-storage company Big Yellow Group will provide  interim management statements. Building products distributer SIG is scheduled to release a 2014 trading statement, recruitment company Michael Page International will issue a fourth quarter trading statement, and ASOS will release a Christmas press statement.

By Neil Thakrar; neilthakrar@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
22 Feb 2024 09:42

TOP NEWS: Hikma boosts dividend after year of "significant progress"

(Alliance News) - Shares in Hikma Pharmaceuticals PLC jumped on Thursday after it lifted the dividend by 29% amid better-than-expected annual profit.

Read more
22 Feb 2024 07:51

Hikma lifts dividend after double-digit growth in 2023

(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Feb 2024 07:23

Hikma agrees to settle US opioid claims

(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on Friday.

Read more
1 Feb 2024 20:00

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2024 09:29

LONDON BROKER RATINGS: Berenberg cuts target prices for miners

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Wednesday:

Read more
20 Dec 2023 09:25

LONDON BROKER RATINGS: UBS cuts DS Smith; Kepler likes Genus

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Dec 2023 09:11

LONDON BROKER RATINGS: Peel Hunt raises Flutter to 'buy' from 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 13:08

Jefferies downgrades Hikma to 'hold'

(Sharecast News) - Jefferies downgraded Hikma Pharmaceuticals on Tuesday to 'hold' from 'buy' and cut the price target to 1,940p from 2,125p.

Read more
7 Nov 2023 09:28

LONDON BROKER RATINGS: Watches of Switzerland impresses HSBC; Asos cut

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 07:43

LONDON BRIEFING: AB Foods hails Primark; Beazley premiums rise

(Alliance News) - London's FTSE 100 is called to open in the red on Tuesday, following Asian equities lower, as the good feeling in equity markets after the softer US jobs data on Friday gives way to some caution.

Read more
6 Nov 2023 12:01

Berenberg stays at 'hold' on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg reiterated their 'hold' rating and 2,100.0p target price on Hikma Pharmaceuticals on Monday, saying a "lighter" second half was playing out in its injectables unit.

Read more
3 Nov 2023 09:31

LONDON BROKER RATINGS: JPMorgan lifts Smith & Nephew

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
2 Nov 2023 15:12

London close: Stocks rise as BoE keeps rates steady

(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.